Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies.

Prieto-Torres L, Rodriguez-Pinilla SM, Onaindia A, Ara M, Requena L, Piris MÁ.

Haematologica. 2019 Feb;104(2):226-235. doi: 10.3324/haematol.2018.197152. Epub 2019 Jan 10. Review.

2.

CD30-Positive Lymphoproliferative Disorders.

Nikolaenko L, Zain J, Rosen ST, Querfeld C.

Cancer Treat Res. 2019;176:249-268. doi: 10.1007/978-3-319-99716-2_12.

PMID:
30596222
3.

MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Kempf W, Kutzner H, Cozzio A, Sander CA, Pfaltz MC, Müller B, Pfaltz M.

Br J Dermatol. 2008 Jun;158(6):1280-7. doi: 10.1111/j.1365-2133.2008.08566.x. Epub 2008 Apr 10.

PMID:
18410414
4.

Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.

Wada DA, Law ME, Hsi ED, Dicaudo DJ, Ma L, Lim MS, Souza Ad, Comfere NI, Weenig RH, Macon WR, Erickson LA, Ozsan N, Ansell SM, Dogan A, Feldman AL.

Mod Pathol. 2011 Apr;24(4):596-605. doi: 10.1038/modpathol.2010.225. Epub 2010 Dec 17.

6.
7.

A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders.

Kempf W.

Semin Diagn Pathol. 2017 Jan;34(1):22-35. doi: 10.1053/j.semdp.2016.11.005. Epub 2016 Nov 29. Review.

PMID:
27993440
8.

Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.

Kummer JA, Vermeer MH, Dukers D, Meijer CJ, Willemze R.

J Invest Dermatol. 1997 Nov;109(5):636-40.

9.

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Kempf W, Pfaltz K, Vermeer MH, Cozzio A, Ortiz-Romero PL, Bagot M, Olsen E, Kim YH, Dummer R, Pimpinelli N, Whittaker S, Hodak E, Cerroni L, Berti E, Horwitz S, Prince HM, Guitart J, Estrach T, Sanches JA, Duvic M, Ranki A, Dreno B, Ostheeren-Michaelis S, Knobler R, Wood G, Willemze R.

Blood. 2011 Oct 13;118(15):4024-35. doi: 10.1182/blood-2011-05-351346. Epub 2011 Aug 12. Review.

10.

Primary cutaneous CD30(+) lymphoproliferative disorders.

Wieser I, Tetzlaff MT, Torres Cabala CA, Duvic M.

J Dtsch Dermatol Ges. 2016 Aug;14(8):767-82. doi: 10.1111/ddg.13117. Review.

PMID:
27509411
11.

Cutaneous CD30-Positive Lymphoproliferative Disorders.

Kempf W.

Surg Pathol Clin. 2014 Jun;7(2):203-28. doi: 10.1016/j.path.2014.02.001. Review.

PMID:
26837199
12.

Cutaneous CD30-positive T-cell lymphoproliferative disorders-clinical and histopathologic features, differential diagnosis, and treatment.

Kempf W, Kerl K, Mitteldorf C.

Semin Cutan Med Surg. 2018 Mar;37(1):24-29. doi: 10.12788/j.sder.2018.001.

PMID:
29719017
13.
14.
15.

Primary cutaneous CD30+ lymphoproliferative disorders: new insights into biology and therapy.

Querfeld C, Kuzel TM, Guitart J, Rosen ST.

Oncology (Williston Park). 2007 May;21(6):689-96; discussion 699-700,. Review.

16.

Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders.

Sciallis AP, Law ME, Inwards DJ, McClure RF, Macon WR, Kurtin PJ, Dogan A, Feldman AL.

Mod Pathol. 2012 Jul;25(7):983-92. doi: 10.1038/modpathol.2012.38. Epub 2012 Mar 2.

17.

CD30+ lymphoproliferative disorders of the skin: still an open question.

Alaibac M, Zarian H, Russo I, Peserico A.

G Ital Dermatol Venereol. 2012 Dec;147(6):545-52.

PMID:
23149700
18.

SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile.

Sun J, Yi S, Qiu L, Fu W, Wang A, Liu F, Wang L, Wang T, Chen H, Wang L, Kadin ME, Tu P, Wang Y.

J Invest Dermatol. 2018 Aug;138(8):1795-1804. doi: 10.1016/j.jid.2018.02.028. Epub 2018 Mar 3.

PMID:
29510190
19.

Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.

Samols MA, Su A, Ra S, Cappel MA, Louissant A Jr, Knudson RA, Ketterling RP, Said J, Binder S, Harris NL, Feldman AL, Kim J, Kim YH, Gratzinger D.

Am J Surg Pathol. 2014 Sep;38(9):1203-11. doi: 10.1097/PAS.0000000000000217.

PMID:
24805854
20.

Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.

De Souza A, Tinguely M, Pfaltz M, Burghart DR, Kempf W.

J Cutan Pathol. 2014 Dec;41(12):901-6. doi: 10.1111/cup.12411. Epub 2014 Nov 25.

PMID:
25353265

Supplemental Content

Support Center